AstraZeneca India Gets CDSCO Approval for Durvalumab’s New Indication
Bengaluru, September 24, 2024: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution for infusion from…